Suppression of p53-dependent senescence by the JNK signal transduction pathway

Madhumita Das1, Feng Jiang, Hayla K Sluss

  • 1Program in Molecular Medicine, Department of Cancer Cell Biology, and Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Insights

The JNK signaling pathway is not essential for cell proliferation but regulates AP1 transcription factors. JNK deficiency leads to p53-dependent senescence, indicating JNK negatively regulates the p53 tumor suppressor.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • The c-Jun N-terminal kinase (JNK) signaling pathway plays a role in regulating the AP1 transcription factor and cell proliferation.
  • Understanding the specific functions of JNK isoforms, JNK1 and JNK2, is crucial for deciphering their roles in cellular processes.

Purpose of the Study:

  • To investigate the role of JNK signaling in cell proliferation and AP1 transcription factor regulation.
  • To determine the necessity of JNK for cell proliferation using conditional and chemical genetic approaches.
  • To elucidate the relationship between JNK signaling and the p53 tumor suppressor pathway.

Main Methods:

  • Utilized conditional and chemical genetic alleles of murine JNK1 and JNK2 genes.
  • Assessed the impact of JNK deficiency on cell proliferation.
  • Analyzed the expression of AP1 transcription factor components (cJun and JunD).
  • Investigated p53-dependent senescence in JNK-deficient cells.

Main Results:

  • JNK signaling is not essential for cell proliferation.
  • JNK is required for the expression of cJun and JunD, key components of the AP1 transcription factor.
  • JNK-deficient cells exhibit premature p53-dependent senescence.
  • JNK acts as a negative regulator of the p53 tumor suppressor.

Conclusions:

  • JNK signaling is dispensable for cell proliferation but critical for AP1 transcription factor activity.
  • JNK deficiency induces early senescence, highlighting a role in tumor suppression.
  • JNK negatively regulates the p53 tumor suppressor, influencing cellular fate decisions.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...